| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Shawver Laura is a Director at ARS Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 50,002 | $12.30 | $615,074.60 | -19.2% | +33.2% | -36.5% | |
| Mar 6, 2025 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 50,000 | $11.21 | $560,445.76 | -10.6% | +28.1% | -16.0% | |
| Feb 3, 2025 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 50,000 | $12.31 | $615,565.00 | -19.2% | +15.8% | -17.5% | |
| Jan 6, 2025 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 50,000 | $11.10 | $555,065.00 | -19.2% | +15.8% | +0.6% | |
| Dec 4, 2024 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 200,000 | $13.44 | $2,688,750.95 | -19.2% | -27.1% | -30.9% | |
| Sep 1, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 100,000 | $7.71 | $770,520.00 | -32.2% | -32.1% | +82.6% | |
| Aug 4, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 45,004 | $7.03 | $316,489.30 | -9.7% | -48.1% | +40.8% | |
| Aug 2, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 54,996 | $7.12 | $391,840.76 | -11.6% | -49.3% | +49.1% | |
| Jul 7, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 8,858 | $6.36 | $56,372.31 | -4.0% | -34.9% | +48.5% | |
| Jul 6, 2023 | SPRY Ars Pharmaceuticals, Inc. | Director | Sale+OE | 91,142 | $6.48 | $590,453.30 | -12.6% | -37.8% | +41.5% |